nodes	percent_of_prediction	percent_of_DWPC	metapath
Sodium stibogluconate—TOP1—myometrium—uterine cancer	0.0305	0.149	CbGeAlD
Sodium stibogluconate—TOP1—uterine cervix—uterine cancer	0.0238	0.116	CbGeAlD
Sodium stibogluconate—TOP1—smooth muscle tissue—uterine cancer	0.0231	0.113	CbGeAlD
Sodium stibogluconate—TOP1—decidua—uterine cancer	0.0226	0.111	CbGeAlD
Sodium stibogluconate—TOP1—endometrium—uterine cancer	0.0215	0.105	CbGeAlD
Sodium stibogluconate—TOP1—mammalian vulva—uterine cancer	0.0208	0.101	CbGeAlD
Sodium stibogluconate—TOP1—uterus—uterine cancer	0.0198	0.0967	CbGeAlD
Sodium stibogluconate—TOP1—female gonad—uterine cancer	0.0162	0.0791	CbGeAlD
Sodium stibogluconate—TOP1—vagina—uterine cancer	0.0161	0.0786	CbGeAlD
Sodium stibogluconate—TOP1—lymph node—uterine cancer	0.0104	0.0508	CbGeAlD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—MAP3K4—uterine cancer	0.00997	0.141	CbGpPWpGaD
Sodium stibogluconate—TOP1—Caspase Cascade in Apoptosis—TNFSF10—uterine cancer	0.00909	0.128	CbGpPWpGaD
Sodium stibogluconate—TOP1—Circadian rythm related genes—STAR—uterine cancer	0.00656	0.0926	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	0.00557	0.0787	CbGpPWpGaD
Sodium stibogluconate—TOP1—Circadian rythm related genes—HNF1B—uterine cancer	0.00535	0.0755	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	0.00357	0.0505	CbGpPWpGaD
Sodium stibogluconate—TOP1—Circadian rythm related genes—EZH2—uterine cancer	0.00343	0.0484	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	0.00331	0.0468	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	0.00301	0.0425	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	0.0027	0.0381	CbGpPWpGaD
Sodium stibogluconate—Flatulence—Progesterone—uterine cancer	0.00239	0.0033	CcSEcCtD
Sodium stibogluconate—Swelling—Etoposide—uterine cancer	0.00233	0.00322	CcSEcCtD
Sodium stibogluconate—Vision blurred—Progesterone—uterine cancer	0.00228	0.00315	CcSEcCtD
Sodium stibogluconate—Cardiac failure congestive—Etoposide—uterine cancer	0.00227	0.00313	CcSEcCtD
Sodium stibogluconate—Lung disorder—Epirubicin—uterine cancer	0.00225	0.0031	CcSEcCtD
Sodium stibogluconate—Syncope—Progesterone—uterine cancer	0.00217	0.003	CcSEcCtD
Sodium stibogluconate—Flatulence—Medroxyprogesterone Acetate—uterine cancer	0.00216	0.00299	CcSEcCtD
Sodium stibogluconate—Dysgeusia—Medroxyprogesterone Acetate—uterine cancer	0.00215	0.00297	CcSEcCtD
Sodium stibogluconate—Palpitations—Progesterone—uterine cancer	0.00214	0.00296	CcSEcCtD
Sodium stibogluconate—Loss of consciousness—Progesterone—uterine cancer	0.00213	0.00294	CcSEcCtD
Sodium stibogluconate—Convulsion—Progesterone—uterine cancer	0.0021	0.0029	CcSEcCtD
Sodium stibogluconate—Lung disorder—Doxorubicin—uterine cancer	0.00208	0.00287	CcSEcCtD
Sodium stibogluconate—Chest pain—Progesterone—uterine cancer	0.00206	0.00285	CcSEcCtD
Sodium stibogluconate—Anxiety—Progesterone—uterine cancer	0.00206	0.00284	CcSEcCtD
Sodium stibogluconate—Feeling hot—Epirubicin—uterine cancer	0.00203	0.0028	CcSEcCtD
Sodium stibogluconate—Necrosis—Epirubicin—uterine cancer	0.00203	0.0028	CcSEcCtD
Sodium stibogluconate—Abscess—Epirubicin—uterine cancer	0.00201	0.00277	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	0.00201	0.0284	CbGpPWpGaD
Sodium stibogluconate—Oedema—Progesterone—uterine cancer	0.00198	0.00273	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Progesterone—uterine cancer	0.00198	0.00273	CcSEcCtD
Sodium stibogluconate—Syncope—Medroxyprogesterone Acetate—uterine cancer	0.00197	0.00272	CcSEcCtD
Sodium stibogluconate—Infection—Progesterone—uterine cancer	0.00197	0.00271	CcSEcCtD
Sodium stibogluconate—Shock—Progesterone—uterine cancer	0.00195	0.00269	CcSEcCtD
Sodium stibogluconate—Palpitations—Medroxyprogesterone Acetate—uterine cancer	0.00194	0.00268	CcSEcCtD
Sodium stibogluconate—Tachycardia—Progesterone—uterine cancer	0.00193	0.00267	CcSEcCtD
Sodium stibogluconate—Loss of consciousness—Medroxyprogesterone Acetate—uterine cancer	0.00193	0.00267	CcSEcCtD
Sodium stibogluconate—Hyperhidrosis—Progesterone—uterine cancer	0.00191	0.00264	CcSEcCtD
Sodium stibogluconate—TOP1—Caspase Cascade in Apoptosis—AKT1—uterine cancer	0.00191	0.0269	CbGpPWpGaD
Sodium stibogluconate—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.0019	0.00263	CcSEcCtD
Sodium stibogluconate—Anorexia—Progesterone—uterine cancer	0.00189	0.0026	CcSEcCtD
Sodium stibogluconate—Necrosis—Doxorubicin—uterine cancer	0.00187	0.00259	CcSEcCtD
Sodium stibogluconate—Feeling hot—Doxorubicin—uterine cancer	0.00187	0.00259	CcSEcCtD
Sodium stibogluconate—Chest pain—Medroxyprogesterone Acetate—uterine cancer	0.00187	0.00258	CcSEcCtD
Sodium stibogluconate—Anxiety—Medroxyprogesterone Acetate—uterine cancer	0.00186	0.00257	CcSEcCtD
Sodium stibogluconate—Abscess—Doxorubicin—uterine cancer	0.00186	0.00257	CcSEcCtD
Sodium stibogluconate—Hypotension—Progesterone—uterine cancer	0.00185	0.00255	CcSEcCtD
Sodium stibogluconate—Extravasation—Epirubicin—uterine cancer	0.00182	0.00252	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.00179	0.00247	CcSEcCtD
Sodium stibogluconate—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.00179	0.00247	CcSEcCtD
Sodium stibogluconate—Infection—Medroxyprogesterone Acetate—uterine cancer	0.00178	0.00246	CcSEcCtD
Sodium stibogluconate—Dysphagia—Etoposide—uterine cancer	0.00178	0.00246	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Progesterone—uterine cancer	0.00178	0.00245	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Progesterone—uterine cancer	0.00176	0.00243	CcSEcCtD
Sodium stibogluconate—Shock—Medroxyprogesterone Acetate—uterine cancer	0.00176	0.00243	CcSEcCtD
Sodium stibogluconate—Bronchospasm—Etoposide—uterine cancer	0.00175	0.00242	CcSEcCtD
Sodium stibogluconate—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.00175	0.00242	CcSEcCtD
Sodium stibogluconate—Cellulitis—Epirubicin—uterine cancer	0.00175	0.00241	CcSEcCtD
Sodium stibogluconate—Hypocalcaemia—Epirubicin—uterine cancer	0.00174	0.0024	CcSEcCtD
Sodium stibogluconate—Sweating increased—Etoposide—uterine cancer	0.00173	0.00239	CcSEcCtD
Sodium stibogluconate—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.00173	0.00239	CcSEcCtD
Sodium stibogluconate—Oliguria—Epirubicin—uterine cancer	0.00173	0.00238	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Progesterone—uterine cancer	0.00172	0.00237	CcSEcCtD
Sodium stibogluconate—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.00171	0.00236	CcSEcCtD
Sodium stibogluconate—Fatigue—Progesterone—uterine cancer	0.00171	0.00235	CcSEcCtD
Sodium stibogluconate—Constipation—Progesterone—uterine cancer	0.00169	0.00234	CcSEcCtD
Sodium stibogluconate—Extravasation—Doxorubicin—uterine cancer	0.00169	0.00233	CcSEcCtD
Sodium stibogluconate—Ulcer—Epirubicin—uterine cancer	0.00168	0.00232	CcSEcCtD
Sodium stibogluconate—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00167	0.00231	CcSEcCtD
Sodium stibogluconate—Creatinine increased—Epirubicin—uterine cancer	0.00167	0.00231	CcSEcCtD
Sodium stibogluconate—Cellulitis—Doxorubicin—uterine cancer	0.00162	0.00223	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Progesterone—uterine cancer	0.00162	0.00223	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.00161	0.00222	CcSEcCtD
Sodium stibogluconate—Hypocalcaemia—Doxorubicin—uterine cancer	0.00161	0.00222	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.0016	0.00221	CcSEcCtD
Sodium stibogluconate—Oliguria—Doxorubicin—uterine cancer	0.0016	0.0022	CcSEcCtD
Sodium stibogluconate—Urticaria—Progesterone—uterine cancer	0.00157	0.00217	CcSEcCtD
Sodium stibogluconate—Acute coronary syndrome—Etoposide—uterine cancer	0.00156	0.00216	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Progesterone—uterine cancer	0.00156	0.00216	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Progesterone—uterine cancer	0.00156	0.00216	CcSEcCtD
Sodium stibogluconate—Renal failure—Etoposide—uterine cancer	0.00156	0.00215	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.00156	0.00215	CcSEcCtD
Sodium stibogluconate—Ulcer—Doxorubicin—uterine cancer	0.00156	0.00215	CcSEcCtD
Sodium stibogluconate—Myocardial infarction—Etoposide—uterine cancer	0.00156	0.00215	CcSEcCtD
Sodium stibogluconate—Creatinine increased—Doxorubicin—uterine cancer	0.00155	0.00213	CcSEcCtD
Sodium stibogluconate—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.00155	0.00213	CcSEcCtD
Sodium stibogluconate—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00153	0.00212	CcSEcCtD
Sodium stibogluconate—Fluid retention—Epirubicin—uterine cancer	0.00151	0.00208	CcSEcCtD
Sodium stibogluconate—Blood urea increased—Epirubicin—uterine cancer	0.0015	0.00207	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	0.00147	0.0208	CbGpPWpGaD
Sodium stibogluconate—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.00147	0.00202	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Progesterone—uterine cancer	0.00146	0.00201	CcSEcCtD
Sodium stibogluconate—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00142	0.00197	CcSEcCtD
Sodium stibogluconate—Asthenia—Progesterone—uterine cancer	0.00142	0.00196	CcSEcCtD
Sodium stibogluconate—Hypoaesthesia—Etoposide—uterine cancer	0.00142	0.00196	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00142	0.00196	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00142	0.00196	CcSEcCtD
Sodium stibogluconate—Pruritus—Progesterone—uterine cancer	0.0014	0.00193	CcSEcCtD
Sodium stibogluconate—Oedema—Dactinomycin—uterine cancer	0.0014	0.00193	CcSEcCtD
Sodium stibogluconate—Fluid retention—Doxorubicin—uterine cancer	0.0014	0.00193	CcSEcCtD
Sodium stibogluconate—Infection—Dactinomycin—uterine cancer	0.00139	0.00192	CcSEcCtD
Sodium stibogluconate—Blood urea increased—Doxorubicin—uterine cancer	0.00139	0.00192	CcSEcCtD
Sodium stibogluconate—Sepsis—Epirubicin—uterine cancer	0.00138	0.0019	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	0.00137	0.0193	CbGpPWpGaD
Sodium stibogluconate—Diarrhoea—Progesterone—uterine cancer	0.00135	0.00187	CcSEcCtD
Sodium stibogluconate—Phlebitis—Epirubicin—uterine cancer	0.00134	0.00185	CcSEcCtD
Sodium stibogluconate—Anorexia—Dactinomycin—uterine cancer	0.00133	0.00184	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00132	0.00182	CcSEcCtD
Sodium stibogluconate—Dizziness—Progesterone—uterine cancer	0.00131	0.00181	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	0.00129	0.0182	CbGpPWpGaD
Sodium stibogluconate—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00129	0.00178	CcSEcCtD
Sodium stibogluconate—Sepsis—Doxorubicin—uterine cancer	0.00128	0.00176	CcSEcCtD
Sodium stibogluconate—Cardiac failure congestive—Epirubicin—uterine cancer	0.00127	0.00176	CcSEcCtD
Sodium stibogluconate—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00127	0.00175	CcSEcCtD
Sodium stibogluconate—Vomiting—Progesterone—uterine cancer	0.00126	0.00174	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	0.00126	0.0178	CbGpPWpGaD
Sodium stibogluconate—Renal failure acute—Epirubicin—uterine cancer	0.00125	0.00173	CcSEcCtD
Sodium stibogluconate—Rash—Progesterone—uterine cancer	0.00125	0.00172	CcSEcCtD
Sodium stibogluconate—Dermatitis—Progesterone—uterine cancer	0.00125	0.00172	CcSEcCtD
Sodium stibogluconate—Phlebitis—Doxorubicin—uterine cancer	0.00124	0.00171	CcSEcCtD
Sodium stibogluconate—Headache—Progesterone—uterine cancer	0.00124	0.00171	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00123	0.00169	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Dactinomycin—uterine cancer	0.00122	0.00168	CcSEcCtD
Sodium stibogluconate—Dysgeusia—Etoposide—uterine cancer	0.00121	0.00168	CcSEcCtD
Sodium stibogluconate—Renal impairment—Epirubicin—uterine cancer	0.00121	0.00167	CcSEcCtD
Sodium stibogluconate—TOP1—Circadian rythm related genes—PTEN—uterine cancer	0.00121	0.017	CbGpPWpGaD
Sodium stibogluconate—Fatigue—Dactinomycin—uterine cancer	0.00121	0.00166	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	0.0012	0.0169	CbGpPWpGaD
Sodium stibogluconate—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00119	0.00164	CcSEcCtD
Sodium stibogluconate—Cerebrovascular accident—Epirubicin—uterine cancer	0.00118	0.00163	CcSEcCtD
Sodium stibogluconate—Cardiac failure congestive—Doxorubicin—uterine cancer	0.00118	0.00163	CcSEcCtD
Sodium stibogluconate—Nausea—Progesterone—uterine cancer	0.00117	0.00162	CcSEcCtD
Sodium stibogluconate—Hyponatraemia—Epirubicin—uterine cancer	0.00116	0.0016	CcSEcCtD
Sodium stibogluconate—Renal failure acute—Doxorubicin—uterine cancer	0.00116	0.0016	CcSEcCtD
Sodium stibogluconate—TOP1—Circadian rythm related genes—EP300—uterine cancer	0.00115	0.0163	CbGpPWpGaD
Sodium stibogluconate—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00114	0.00158	CcSEcCtD
Sodium stibogluconate—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00114	0.00157	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	0.00114	0.016	CbGpPWpGaD
Sodium stibogluconate—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00113	0.00156	CcSEcCtD
Sodium stibogluconate—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00113	0.00156	CcSEcCtD
Sodium stibogluconate—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00112	0.00155	CcSEcCtD
Sodium stibogluconate—Renal impairment—Doxorubicin—uterine cancer	0.00112	0.00155	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Dactinomycin—uterine cancer	0.00111	0.00153	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Dactinomycin—uterine cancer	0.00111	0.00153	CcSEcCtD
Sodium stibogluconate—Loss of consciousness—Etoposide—uterine cancer	0.00109	0.0015	CcSEcCtD
Sodium stibogluconate—Cerebrovascular accident—Doxorubicin—uterine cancer	0.00109	0.0015	CcSEcCtD
Sodium stibogluconate—Blood creatinine increased—Epirubicin—uterine cancer	0.00108	0.00149	CcSEcCtD
Sodium stibogluconate—Convulsion—Etoposide—uterine cancer	0.00107	0.00148	CcSEcCtD
Sodium stibogluconate—Dehydration—Epirubicin—uterine cancer	0.00107	0.00148	CcSEcCtD
Sodium stibogluconate—Hyponatraemia—Doxorubicin—uterine cancer	0.00107	0.00148	CcSEcCtD
Sodium stibogluconate—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00106	0.00147	CcSEcCtD
Sodium stibogluconate—Chest pain—Etoposide—uterine cancer	0.00106	0.00146	CcSEcCtD
Sodium stibogluconate—Hypokalaemia—Epirubicin—uterine cancer	0.00105	0.00145	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Dactinomycin—uterine cancer	0.00103	0.00142	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Etoposide—uterine cancer	0.00101	0.0014	CcSEcCtD
Sodium stibogluconate—Infection—Etoposide—uterine cancer	0.00101	0.00139	CcSEcCtD
Sodium stibogluconate—Abdominal distension—Epirubicin—uterine cancer	0.001	0.00139	CcSEcCtD
Sodium stibogluconate—Asthenia—Dactinomycin—uterine cancer	0.001	0.00138	CcSEcCtD
Sodium stibogluconate—Blood creatinine increased—Doxorubicin—uterine cancer	0.001	0.00138	CcSEcCtD
Sodium stibogluconate—Dysphagia—Epirubicin—uterine cancer	0.000997	0.00138	CcSEcCtD
Sodium stibogluconate—Dehydration—Doxorubicin—uterine cancer	0.000993	0.00137	CcSEcCtD
Sodium stibogluconate—Tachycardia—Etoposide—uterine cancer	0.000988	0.00136	CcSEcCtD
Sodium stibogluconate—Hyperhidrosis—Etoposide—uterine cancer	0.000978	0.00135	CcSEcCtD
Sodium stibogluconate—Hypokalaemia—Doxorubicin—uterine cancer	0.000972	0.00134	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	0.000966	0.0136	CbGpPWpGaD
Sodium stibogluconate—Anorexia—Etoposide—uterine cancer	0.000965	0.00133	CcSEcCtD
Sodium stibogluconate—Bronchitis—Epirubicin—uterine cancer	0.000959	0.00132	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Dactinomycin—uterine cancer	0.000957	0.00132	CcSEcCtD
Sodium stibogluconate—Hypotension—Etoposide—uterine cancer	0.000946	0.00131	CcSEcCtD
Sodium stibogluconate—Abdominal distension—Doxorubicin—uterine cancer	0.000929	0.00128	CcSEcCtD
Sodium stibogluconate—Dysphagia—Doxorubicin—uterine cancer	0.000923	0.00127	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Etoposide—uterine cancer	0.000909	0.00125	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Etoposide—uterine cancer	0.000902	0.00125	CcSEcCtD
Sodium stibogluconate—Vomiting—Dactinomycin—uterine cancer	0.000889	0.00123	CcSEcCtD
Sodium stibogluconate—Bronchitis—Doxorubicin—uterine cancer	0.000888	0.00123	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	0.000887	0.0125	CbGpPWpGaD
Sodium stibogluconate—Rash—Dactinomycin—uterine cancer	0.000882	0.00122	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Etoposide—uterine cancer	0.00088	0.00121	CcSEcCtD
Sodium stibogluconate—Renal failure—Epirubicin—uterine cancer	0.000874	0.00121	CcSEcCtD
Sodium stibogluconate—Fatigue—Etoposide—uterine cancer	0.000872	0.0012	CcSEcCtD
Sodium stibogluconate—Constipation—Etoposide—uterine cancer	0.000865	0.00119	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	0.000858	0.0121	CbGpPWpGaD
Sodium stibogluconate—Nausea—Dactinomycin—uterine cancer	0.00083	0.00115	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Etoposide—uterine cancer	0.000827	0.00114	CcSEcCtD
Sodium stibogluconate—TOP1—Circadian rythm related genes—TP53—uterine cancer	0.000824	0.0116	CbGpPWpGaD
Sodium stibogluconate—Renal failure—Doxorubicin—uterine cancer	0.000809	0.00112	CcSEcCtD
Sodium stibogluconate—Urticaria—Etoposide—uterine cancer	0.000804	0.00111	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Etoposide—uterine cancer	0.0008	0.0011	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Etoposide—uterine cancer	0.0008	0.0011	CcSEcCtD
Sodium stibogluconate—Hypoaesthesia—Epirubicin—uterine cancer	0.000794	0.0011	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Etoposide—uterine cancer	0.000746	0.00103	CcSEcCtD
Sodium stibogluconate—Hypoaesthesia—Doxorubicin—uterine cancer	0.000735	0.00101	CcSEcCtD
Sodium stibogluconate—Asthenia—Etoposide—uterine cancer	0.000726	0.001	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	0.000725	0.0102	CbGpPWpGaD
Sodium stibogluconate—Pruritus—Etoposide—uterine cancer	0.000716	0.000988	CcSEcCtD
Sodium stibogluconate—Arrhythmia—Epirubicin—uterine cancer	0.000713	0.000985	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Etoposide—uterine cancer	0.000692	0.000956	CcSEcCtD
Sodium stibogluconate—Flatulence—Epirubicin—uterine cancer	0.000685	0.000946	CcSEcCtD
Sodium stibogluconate—Dysgeusia—Epirubicin—uterine cancer	0.000681	0.00094	CcSEcCtD
Sodium stibogluconate—Dizziness—Etoposide—uterine cancer	0.000669	0.000924	CcSEcCtD
Sodium stibogluconate—Arrhythmia—Doxorubicin—uterine cancer	0.00066	0.000911	CcSEcCtD
Sodium stibogluconate—Vision blurred—Epirubicin—uterine cancer	0.000655	0.000904	CcSEcCtD
Sodium stibogluconate—Vomiting—Etoposide—uterine cancer	0.000643	0.000888	CcSEcCtD
Sodium stibogluconate—Rash—Etoposide—uterine cancer	0.000638	0.000881	CcSEcCtD
Sodium stibogluconate—Dermatitis—Etoposide—uterine cancer	0.000637	0.00088	CcSEcCtD
Sodium stibogluconate—Headache—Etoposide—uterine cancer	0.000634	0.000875	CcSEcCtD
Sodium stibogluconate—Flatulence—Doxorubicin—uterine cancer	0.000634	0.000875	CcSEcCtD
Sodium stibogluconate—Dysgeusia—Doxorubicin—uterine cancer	0.00063	0.000869	CcSEcCtD
Sodium stibogluconate—Syncope—Epirubicin—uterine cancer	0.000623	0.00086	CcSEcCtD
Sodium stibogluconate—Palpitations—Epirubicin—uterine cancer	0.000614	0.000848	CcSEcCtD
Sodium stibogluconate—Loss of consciousness—Epirubicin—uterine cancer	0.000611	0.000843	CcSEcCtD
Sodium stibogluconate—Vision blurred—Doxorubicin—uterine cancer	0.000606	0.000837	CcSEcCtD
Sodium stibogluconate—Convulsion—Epirubicin—uterine cancer	0.000602	0.000831	CcSEcCtD
Sodium stibogluconate—Nausea—Etoposide—uterine cancer	0.000601	0.00083	CcSEcCtD
Sodium stibogluconate—Chest pain—Epirubicin—uterine cancer	0.000592	0.000817	CcSEcCtD
Sodium stibogluconate—Anxiety—Epirubicin—uterine cancer	0.00059	0.000814	CcSEcCtD
Sodium stibogluconate—Syncope—Doxorubicin—uterine cancer	0.000577	0.000796	CcSEcCtD
Sodium stibogluconate—Palpitations—Doxorubicin—uterine cancer	0.000568	0.000785	CcSEcCtD
Sodium stibogluconate—Oedema—Epirubicin—uterine cancer	0.000567	0.000783	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Epirubicin—uterine cancer	0.000567	0.000783	CcSEcCtD
Sodium stibogluconate—Loss of consciousness—Doxorubicin—uterine cancer	0.000565	0.00078	CcSEcCtD
Sodium stibogluconate—Infection—Epirubicin—uterine cancer	0.000564	0.000778	CcSEcCtD
Sodium stibogluconate—Shock—Epirubicin—uterine cancer	0.000558	0.00077	CcSEcCtD
Sodium stibogluconate—Convulsion—Doxorubicin—uterine cancer	0.000557	0.000769	CcSEcCtD
Sodium stibogluconate—Tachycardia—Epirubicin—uterine cancer	0.000554	0.000764	CcSEcCtD
Sodium stibogluconate—Hyperhidrosis—Epirubicin—uterine cancer	0.000548	0.000757	CcSEcCtD
Sodium stibogluconate—Chest pain—Doxorubicin—uterine cancer	0.000548	0.000756	CcSEcCtD
Sodium stibogluconate—Anxiety—Doxorubicin—uterine cancer	0.000546	0.000753	CcSEcCtD
Sodium stibogluconate—Anorexia—Epirubicin—uterine cancer	0.000541	0.000746	CcSEcCtD
Sodium stibogluconate—Hypotension—Epirubicin—uterine cancer	0.00053	0.000732	CcSEcCtD
Sodium stibogluconate—Oedema—Doxorubicin—uterine cancer	0.000525	0.000725	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Doxorubicin—uterine cancer	0.000525	0.000725	CcSEcCtD
Sodium stibogluconate—Infection—Doxorubicin—uterine cancer	0.000521	0.00072	CcSEcCtD
Sodium stibogluconate—Shock—Doxorubicin—uterine cancer	0.000516	0.000713	CcSEcCtD
Sodium stibogluconate—Tachycardia—Doxorubicin—uterine cancer	0.000512	0.000707	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Epirubicin—uterine cancer	0.000509	0.000703	CcSEcCtD
Sodium stibogluconate—Hyperhidrosis—Doxorubicin—uterine cancer	0.000507	0.0007	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Epirubicin—uterine cancer	0.000506	0.000698	CcSEcCtD
Sodium stibogluconate—Anorexia—Doxorubicin—uterine cancer	0.0005	0.000691	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Epirubicin—uterine cancer	0.000493	0.000681	CcSEcCtD
Sodium stibogluconate—Hypotension—Doxorubicin—uterine cancer	0.00049	0.000677	CcSEcCtD
Sodium stibogluconate—Fatigue—Epirubicin—uterine cancer	0.000489	0.000675	CcSEcCtD
Sodium stibogluconate—Constipation—Epirubicin—uterine cancer	0.000485	0.00067	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Doxorubicin—uterine cancer	0.000471	0.000651	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Doxorubicin—uterine cancer	0.000468	0.000646	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Epirubicin—uterine cancer	0.000464	0.00064	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Doxorubicin—uterine cancer	0.000456	0.00063	CcSEcCtD
Sodium stibogluconate—Fatigue—Doxorubicin—uterine cancer	0.000453	0.000625	CcSEcCtD
Sodium stibogluconate—Urticaria—Epirubicin—uterine cancer	0.000451	0.000622	CcSEcCtD
Sodium stibogluconate—Constipation—Doxorubicin—uterine cancer	0.000449	0.00062	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Epirubicin—uterine cancer	0.000448	0.000619	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Epirubicin—uterine cancer	0.000448	0.000619	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000429	0.000593	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Epirubicin—uterine cancer	0.000418	0.000577	CcSEcCtD
Sodium stibogluconate—Urticaria—Doxorubicin—uterine cancer	0.000417	0.000576	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Doxorubicin—uterine cancer	0.000415	0.000573	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Doxorubicin—uterine cancer	0.000415	0.000573	CcSEcCtD
Sodium stibogluconate—Asthenia—Epirubicin—uterine cancer	0.000407	0.000562	CcSEcCtD
Sodium stibogluconate—Pruritus—Epirubicin—uterine cancer	0.000401	0.000554	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Epirubicin—uterine cancer	0.000388	0.000536	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Doxorubicin—uterine cancer	0.000387	0.000534	CcSEcCtD
Sodium stibogluconate—Asthenia—Doxorubicin—uterine cancer	0.000377	0.00052	CcSEcCtD
Sodium stibogluconate—Dizziness—Epirubicin—uterine cancer	0.000375	0.000518	CcSEcCtD
Sodium stibogluconate—Pruritus—Doxorubicin—uterine cancer	0.000371	0.000513	CcSEcCtD
Sodium stibogluconate—Vomiting—Epirubicin—uterine cancer	0.000361	0.000498	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Doxorubicin—uterine cancer	0.000359	0.000496	CcSEcCtD
Sodium stibogluconate—Rash—Epirubicin—uterine cancer	0.000358	0.000494	CcSEcCtD
Sodium stibogluconate—Dermatitis—Epirubicin—uterine cancer	0.000357	0.000493	CcSEcCtD
Sodium stibogluconate—Headache—Epirubicin—uterine cancer	0.000355	0.000491	CcSEcCtD
Sodium stibogluconate—Dizziness—Doxorubicin—uterine cancer	0.000347	0.000479	CcSEcCtD
Sodium stibogluconate—Nausea—Epirubicin—uterine cancer	0.000337	0.000465	CcSEcCtD
Sodium stibogluconate—Vomiting—Doxorubicin—uterine cancer	0.000334	0.000461	CcSEcCtD
Sodium stibogluconate—Rash—Doxorubicin—uterine cancer	0.000331	0.000457	CcSEcCtD
Sodium stibogluconate—Dermatitis—Doxorubicin—uterine cancer	0.000331	0.000456	CcSEcCtD
Sodium stibogluconate—Headache—Doxorubicin—uterine cancer	0.000329	0.000454	CcSEcCtD
Sodium stibogluconate—Nausea—Doxorubicin—uterine cancer	0.000312	0.00043	CcSEcCtD
